These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7961004)

  • 61. Patterns of lymph node positivity on
    McClinton C; Niroumand M; Sood S; Shah V; Hill J; Dusing RW; Shen X
    Pract Radiat Oncol; 2017; 7(5):325-331. PubMed ID: 28377141
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Elective inguinal lymph node irradiation for pelvic carcinomas. The University of Florida experience.
    Lee WR; McCollough WM; Mendenhall WM; Marcus RB; Parsons JT; Million RR
    Cancer; 1993 Sep; 72(6):2058-65. PubMed ID: 8364884
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
    N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
    Perez CA; Michalski J; Brown KC; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography.
    Vinnicombe SJ; Norman AR; Nicolson V; Husband JE
    Radiology; 1995 Feb; 194(2):349-55. PubMed ID: 7824709
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Internal mammary node coverage: an investigation of presently accepted techniques.
    Arthur DW; Arnfield MR; Warwicke LA; Morris MM; Zwicker RD
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):139-46. PubMed ID: 10924983
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical utility of the modified segmental boost technique for treatment of the pelvis and inguinal nodes.
    Moran MS; Castrucci WA; Ahmad M; Song H; Lund MW; Mani S; Chamberlain D; Higgins SA
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1026-36. PubMed ID: 19596174
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Different radiation techniques to deliver therapeutic dose to the axilla in patients with sentinel lymph node-positive breast cancer: Doses, techniques challenges and clinical considerations.
    Wang S; Kirova YM; Shan SC; Cai G; Ou D; Cao L; Cai R; Chen JY
    Cancer Radiother; 2018 Dec; 22(8):767-772. PubMed ID: 30523794
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage II.
    Fuller LM; Mirza NQ; Palmer JL; Davis BR; Ha CS; Rodriguez MA; Hagemeister FB; Cabanillas F; McLaughlin P; Butler JJ; North LB; Martin RG
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):377-86. PubMed ID: 9457824
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].
    Li FM; Luo W; He ZC; Zhang L; Sun Y; Qin WJ; Lu LX; Han F; Liu XQ; Liu MZ
    Ai Zheng; 2007 Oct; 26(10):1127-32. PubMed ID: 17927886
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Preservation of ovarian function in 2 young women with Hodgkin disease by laparoscopic transposition of the ovaries prior to abdominal irradiation].
    Tinga DJ; Dolsma WV; Tamminga RY; van der Zee AG
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):308-12. PubMed ID: 10221088
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.
    Girinsky T; Specht L; Ghalibafian M; Edeline V; Bonniaud G; Van Der Maazen R; Aleman B; Paumier A; Meijnders P; Lievens Y; Noordijk E; Poortmans P;
    Radiother Oncol; 2008 Aug; 88(2):202-10. PubMed ID: 18555548
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adequate irradiation of the internal jugular lymph node chain: technical considerations.
    Aref A; Gross M; Fontanesi J; Devi S; Kopel C; Thornton D
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):269-73. PubMed ID: 9069296
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recovery of spermatogenesis following pelvic irradiation for Hodgkin's disease.
    Pedrick TJ; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1986 Jan; 12(1):117-21. PubMed ID: 3943983
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of segmental boost fields in the irradiation of inguinal lymphatic nodes.
    Watson BA; Tatro DS; Ten Haken RK; Schewe JE; Possert PW; Sullivan MA
    Med Dosim; 1999; 24(1):27-32. PubMed ID: 10100162
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of lymphangiography in designing fields for elective pelvic node irradiation in Hodgkin's disease.
    Mendenhall NP; Holland KW; Sombeck MD
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):993-5. PubMed ID: 7961004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.